rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Accendra Health, Inc.

ACH · NYSE

IndustrialsDistributors & WholesaleNot moving yet

ACH stood above a rising 150-day average in 4 of the last 52 weekly readings, and has been out of that trend for the last 11 weeks. It is 89.8% below that average now. Distributors & Wholesale: 40% of its 78 stocks in an uptrend (+10 points in four weeks); Industrials: 27% (−4 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 11
Industry in uptrend
40% +10 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
134 (+2)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 4 of 52 weeks.

17 Apr – 16 Oct
27%37%46%Apr 26Jun 26Jul 26Sep 26Oct 26

Distributors & Wholesale: A minority of its stocks are in an uptrend and the share has climbed sharply over four weeks. Industrials: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$15.7MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders134+2 on the quarter
New · exited23 · 21
Reported value$219.8M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Coliseum Capital Management, LLCunchanged · filed 14 Aug 202613,100,807$44.8M00.0%
BlackRock, Inc.added · filed 7 Aug 20265,504,102$18.8M+268,802+5.1%
BANK OF AMERICA CORPadded · filed 14 Aug 20263,775,525$12.9M+368,450+10.8%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 20263,087,931$10.6M-194,243−5.9%
D. E. Shaw & Co., Inc.reduced · filed 14 Aug 20263,081,407$10.5M-230,194−7.0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INCreduced · filed 14 Aug 20262,888,058$9.9M-747,468−20.6%
Sixth Street Partners Management Company, L.P.new · filed 14 Aug 20262,888,058$9.9M+2,888,058
Invenomic Capital Management LPreduced · filed 14 Aug 20262,812,474$9.6M-556,501−16.5%
MARSHALL WACE, LLPadded · filed 13 Aug 20262,582,579$8.8M+821,575+46.7%
PARADIGM CAPITAL MANAGEMENT INCadded · filed 13 Aug 20262,536,699$8.7M+750,299+42.0%
31 Mar 2023 – 30 Jun 2026
135176216Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Kenneth Gardner-Smith Company insiderPresident & CEO · last 5 Oct 20260 · 0
Jonathan A. Leon Company insiderEVP & CFO · last 23 Sep 20260 · 13
Heath H. Galloway Company insiderEVP, General Counsel & CorpSecy · last 18 May 20260 · 4
Edward A. Pesicka Company insiderPresident & CEO · last 15 May 20260 · 12
Perry A. Bernocchi Company insiderEVP, Chief Operating Officer · last 15 May 20260 · 3
Gwendolyn M. Bingham Company insiderDirector · last 14 May 20260 · 1
Mark A. Beck Company insiderDirector · last 14 May 20260 · 1
Stephen W. Klemash Company insiderDirector · last 14 May 20260 · 0
Teresa L. Kline Company insiderDirector · last 14 May 20260 · 0
Andrew G. Long Company insiderEVP, CEO P&HS · last 19 Nov 20250 · 2
Coliseum Capital Partners, L.p. Company insider10% owner · last 14 Aug 20253 · 0
Jennifer A. Stone Company insiderEVP, CHRO · last 3 Jun 20250 · 0

Same industry

WEYS Weyco GroupLeading+31%
SCSC ScanSourceLeading+21%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202546.7%
Operating profit marginFY 2025 · to 31 Dec 20251.0%
Free cash flow marginFY 2025 · to 31 Dec 2025-10.6%
Return on capital employedFY 2025 · to 31 Dec 20251.8%
Debt to equityFY 2024 · to 31 Dec 20240.08×
Interest coverFY 2025 · to 31 Dec 20250.26×
Research spendFY 2024 · to 31 Dec 20240.1%
Share count trendFY 2025 · to 31 Jan 20260.1%
Cash and equivalentsFY 2025 · to 31 Dec 2025$282.0M
Free cash flowFY 2025 · to 31 Dec 2025−$292.7M

Analyst forecasts

No analyst forecasts yet.